Q2 2025 has demonstrated the pharmaceutical industry’s continued momentum in developing transformative therapies across ...

Neha Anand, Analyst, Biopharma Intelligence Services, Citeline, explains how the approval of Embrelis marks a pivotal moment ...

IHH Healthcare Berhad strengthens India presence through collaboration between Fortis Healthcare and Gleneagles Healthcare India for growth.

There is increased risk for major gastrointestinal bleeding with edoxaban vs VKA therapy in patients with atrial fibrillation following TAVR.

An analysis of SEER registry data published in 2003 revealed for the first time a troubling rise in colorectal cancer among young adults in the United States.Since then, most published papers and ...

The ROR inhibitors market is witnessing steady growth driven by the increasing understanding of receptor tyrosine kinase-like orphan receptor ...